4//SEC Filing
Ferrante Karen Jean 4
Accession 0000950170-25-082374
CIK 0001622229other
Filed
Jun 4, 8:00 PM ET
Accepted
Jun 5, 4:25 PM ET
Size
5.4 KB
Accession
0000950170-25-082374
Insider Transaction Report
Form 4
Ferrante Karen Jean
Director
Transactions
- Award
Stock Option (Right to Buy)
2025-06-04+44,700→ 44,700 totalExercise: $5.64Exp: 2035-06-04→ Common Stock (44,700 underlying)
Footnotes (1)
- [F1]This stock option shall vest in full upon the earlier of the first anniversary of the date of grant or the date of the 2026 Annual Meeting of Stockholders.
Documents
Issuer
Cogent Biosciences, Inc.
CIK 0001622229
Entity typeother
Related Parties
1- filerCIK 0001598502
Filing Metadata
- Form type
- 4
- Filed
- Jun 4, 8:00 PM ET
- Accepted
- Jun 5, 4:25 PM ET
- Size
- 5.4 KB